2. 您的位置
3. 首页
4. 会议论文
5. Endoscopic Submucosal Dissection in Patients with Submucosal Tumors of Rectum

Endoscopic Submucosal Dissection in Patients with Submucosal Tumors of Rectum

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户：shy19780928

【摘 要】

：

Submucosal tumors (SMT) can be seen in the rectum during colonoscopy.Most of the SMT in the rectum present in the lower of the rectum,and the kinds of the tumor can be seen neuroendocrine tumor (NET),

【作 者】

：

Satoshi Suehiro Hideaki Harada 

【机 构】

：

New Tokyo Hospital Japan

【出 处】

：

2016第九届世界癌症大会

【发表日期】

：

2016年7期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Submucosal tumors (SMT) can be seen in the rectum during colonoscopy.Most of the SMT in the rectum present in the lower of the rectum,and the kinds of the tumor can be seen neuroendocrine tumor (NET),leiomyoma,and so on.

其他文献

Prevalence of Lung Cancer Among Women Never Smokers at Adam Malik General Hospital, Medan, Indonesia

Lung cancer in never smokers patients is on the seventh rank,the most common cause of cancer-related mortality,then it is followed by cancers of the cervix,pancreas,and prostate.

会议

siRNA Delivered by EGFR-specific scFv Sensitizes EGFR-TKI-resistant Human Lung Cancer Cells

The overexpression of epidermal growth factor receptor (EGFR) is closely associated with a poor outcome in non-small cell lung cancer (NSCLC),and EGFR is an ideal biomarker for the targeted therapy of

会议

Multiple Primary Malignancies Involving Lung Cancer

Background: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades.However,the clinical characteristics and prognosis of MPM patients involving lung cancer were n

会议

A Multimodality Approach to the Treatment of Locally Advanced Non Small Cell Lung Cancer

Lung cancer is the most common cause of cancer death in developed countries.The prognosis is poor,with less than 15% of patients surviving 5 years after diagnosis.

会议

Treatment of Patients with EGFR Mutation-positive Non-small Cell Lung Cancer: What's New and Wh

Advanced non-small-cell lung cancer (NSCLC) is a heterogeneous and difficult-to-treat disease.Advances in the understanding of N SCLC pathogenesis have led to identification of molecular "drivers" of

会议

Updates in Small Cell Lung Cancer

Small cell lung cancer represents about 13-18% of all lung cancers.It is characterized by early metastases and high mortality.It is important to remember that a small percentage of patients presenting

会议

Gut Microbiome: A Potential Regulator of Cancer Stem Cells and Colon Carcinogenesis

The concept that pluripotent cancer stem cells (CSCs) are involved in the development and progression of many types of malignancies,including colorectal cancer (CRC),is now well accepted.

会议

The Impact of Peri-operative Blood Transfusion on Patients with Gastric Cancer Receiving Gastrectomy

The potential disadvantages of blood transfusion during curative gastrectomy for gastric cancer were reported,and the role of peri-operative blood transfusion remained to be ascertained.

会议

Gastric Cancer: Molecular and Histogenetic Particularities in Western and Eastern Countries

Gastric cancer (GC) is one of the main causes of cancer death in Europe.In Japan,the well-conducted screening programmes significantly decreased the rate of mortality but the incidence is still increa

会议

Brief Review: Diagnosis and Management of Cystic Pancreatic Neoplasm

Pancreatic cancer often goes undetected until its advanced and difficult to treat.In the vast majority of cases,symptoms only develop after has grown and begun to spread.

会议